GlassScriptPhysician profile
C B Bowling
NPI 1255398004
$51,652.54
in general payments reported to CMS, 2019-2025
21 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $22K · 2021: $1,617 · 2022: $851 · 2023: $3,377 · 2024: $6,712 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,200 · Food and Beverage: $3,244 · Travel and Lodging: $2,682 · Gift: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,200.00 |
| Food and Beverage | $3,243.84 |
| Travel and Lodging | $2,681.72 |
| Gift | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $37,328.37 | 2019-2025 | Desara |
| Boston Scientific Corporation | $10,827.33 | 2019-2025 | Uromax Ultra, Solyx Sis System, Advantage System |
| Axonics, INC. | $2,288.15 | 2020-2023 | Axonics |
| Sumitomo Pharma America, INC. | $295.82 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $189.03 | 2022 | |
| Pfizer INC. | $180.43 | 2019-2021 | |
| Astellas Pharma US INC | $127.77 | 2019-2022 | |
| Therapeuticsmd, INC. | $71.27 | 2019 | |
| Acera Surgical, INC. | $55.97 | 2025 | Restrata Wound Matrix |
| 180 Medical, INC. | $48.47 | 2022-2024 | |
| Laborie Medical Technologies Corp. | $37.85 | 2025 | |
| Abbvie INC. | $29.96 | 2025 | |
| Medtronic USA, INC. | $24.50 | 2019 | |
| Coloplast Corp | $24.09 | 2022 | |
| Olympus America INC. | $19.84 | 2025 | Olympus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $19.74 | 2025 | Lofric |
| Ambu INC. | $19.74 | 2024 | |
| Rochester Medical Corporation | $18.74 | 2020 | |
| Allergan, INC. | $15.51 | 2020 | |
| Covidien LP | $15.06 | 2019 | |
| Abc Home Medical Supply, INC. | $14.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw C Bowling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.